Medicox, Up 5.56% on Rising Theme of COVID-19 (Treatment/Vaccine Development)

On the 18th, the COVID-19 (treatment/vaccine development, etc.) theme rose by 3.03% compared to the previous day, showing strength, while Medicox, a related stock drawing attention, surged by 5.56% compared to the previous day. Medicox is known as a block manufacturing shipbuilding equipment company.

[Graph] Major stock price changes in the COVID-19 (treatment/vaccine development, etc.) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Medicox's quant financial score was 11.96 points, ranking 13th in the quant financial ranking within the COVID-19 (treatment/vaccine development, etc.) related theme. This can be interpreted as Medicox having relatively low investment attractiveness from a financial perspective. On the other hand, United Pharm ranked first in the quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.